What's Next for Affymax, Inc. (AFFY)?
Affymax, Inc. (NASDAQ:AFFY) received its first Food and Drug Administration approval last spring with Omontys for anemia in dialysis patients. The drug enters a war against Amgen, Inc.
Amgen Inc (AMGN)
Market is closed
News
- First
- << Previous
- 381 - 382
Biotech: Core and Explore - Pfizer Inc. (PFE), Merck & Co., Inc. (MRK)
Giant pharmaceutical companies are looking for the next big drug, and so are much smaller biotech outfits. Because of the methods they use, biotechs are often at the leading edge of research.
- First
- << Previous
- 381 - 382
Billionaire Hedge Funds
